Comparison of treatments for persistent/chronic immune thrombocytopenia: a systematic review and network meta-analysis
Recent studies have indicated that medical options without splenectomy, such as rituximab (RTX) or thrombopoietin receptor agonists (TPO-RAs), can be effective to treat persistent or chronic primary immune thrombocytopenia (ITP). However, it remains to be determined which of these strategies should...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis Group
2019-11-01
|
| coleção: | Platelets |
| Assuntos: | |
| Acesso em linha: | http://dx.doi.org/10.1080/09537104.2018.1543864 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|